Benefits of aflibercept treatment for age-related macular degeneration patients with good best-corrected visual acuity at baseline

Currently, age-related macular degeneration (AMD) is treated while patients exhibit good best-corrected visual acuity (BCVA). However, previous clinical trials only include patients with poor BCVA. We prospectively analyzed the benefits of intravitreal aflibercept (IVA) treatment for AMD patients ex...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Sci Rep
Hauptverfasser: Minami, Sakiko, Nagai, Norihiro, Suzuki, Misa, Kurihara, Toshihide, Sonobe, Hideki, Kamoshita, Mamoru, Uchida, Atsuro, Shinoda, Hajime, Takagi, Hitoshi, Sonoda, Shozo, Sakamoto, Taiji, Tsubota, Kazuo, Ozawa, Yoko
Format: Artigo
Sprache:Inglês
Veröffentlicht: Nature Publishing Group UK 2018
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5758719/
https://ncbi.nlm.nih.gov/pubmed/29311612
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-18255-4
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge